On March 11, 2021 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, reported that James Caruso, president and CEO, will present a company overview and be available for 1×1 meetings at the following upcoming conferences (Press release, Cellectar Biosciences, MAR 11, 2021, View Source [SID1234576482]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 31st Annual Healthcare Conference

Date: March 16, 2021
Presentation Time: 8:00 am ET
Available for 1×1 meetings
Webcast: To register, click on the link HERE
Maxim Group 2021 Emerging Growth Virtual Conference

Date: March 17-19, 2021
Webcast: To register, click on the link HERE
The company’s presentation is available for on-demand viewing in the link HERE.